Latest Proprietary Technology News

Mesoblast has been granted a seven-year orphan-drug exclusivity by the FDA for its cell therapy Ryoncil, reinforcing its market position in treating steroid-refractory acute graft versus host disease in children.

Australian Bond Exchange Holdings (ASX: ABE) announces the resignation of director Anthony Hartman and the appointment of Robert Shaw and Mark O’Leary to its board, signaling a strategic boost in expertise.

LTR Pharma has partnered with Strategic Drug Solutions to co-develop OROFLOW®, a novel intranasal spray aimed at providing fast symptom relief for Oesophageal Motility Disorders, tapping into a growing $4.5 billion global market.

Computershare Limited reaffirmed its FY25 guidance at the Macquarie Australia Conference, projecting a 15% increase in management EPS supported by strong revenue growth and disciplined capital management.

Vection Technologies has landed a $1.2 million grant to lead an innovative XR and AI digital twin project aimed at transforming real-time product intelligence in food and beverage manufacturing.

Nanollose Limited has achieved a significant milestone by blending its Nullarbor-20™ sustainable fibre with Australian merino wool to produce pilot blankets, while also completing a $672,000 placement to fund ongoing commercialisation efforts.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

NoviqTech has advanced its blockchain-based sustainability solutions, pioneering real-world asset tokenisation and expanding its investor base through OTCQB trading in the US.

Australian Bond Exchange Holdings (ASX: ABE) reported a strong $3.6 billion trading volume for Q3 FY25 and announced a strategic partnership with ViewTrade Australia, while securing $1.8 million in funding to support its growth trajectory.

Wisr has upgraded its FY25 loan origination growth guidance to over 90%, driven by a 115% surge in Q3FY25 loan originations and improved credit quality metrics. The fintech lender’s disciplined growth and technology investments position it well for scaling in a shifting personal and vehicle lending market.

DataWorks Group Limited has secured a two-year extension on its BetStop self-exclusion contract and is advancing its global RegTech pipeline, aiming for positive operating cash flow by December 2025.

Harmoney has raised its FY25 cash NPAT guidance to $5.5 million and announced an on-market share buy-back, setting the stage for accelerated loan book growth and improved returns in FY26.